Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deep Versus Moderate Neuromuscular Blockade During Total HIP Replacement Surgery to Improve POstoperative Quality of Recovery and Immune Function: a Randomized Controlled Study

NCT05562999 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT05562999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05562999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deep Versus Moderate Neuromuscular Blockade During Total HIP Replacement Surgery to Improve POstoperative Quality of Recovery and Immune Function: a Randomized Controlled Study
Lead sponsor
Radboud University Medical Center
Phase
Phase 4
Overall status
Completed
Start date
November 18, 2022
Completion date
August 29, 2024
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

innate inflammatory response, neuromuscular blockade, postoperative complications, quality of life